Apologies if this has been posted already, an interesting article about the trials and tribulations of Ovid Therapeutics developing a therapy for Angelman Syndrome. Neuren briefly mentioned.
https://www.spectrumnews.org/features/deep-dive/what-next-for-angelman/
Share Price, page-2547
-
- There are more pages in this discussion • 9,524 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.16 |
Change
-0.115(0.75%) |
Mkt cap ! $1.930B | |||
| Open | High | Low | Value | Volume |
| $15.38 | $15.47 | $14.93 | $4.677M | 310.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 349 | $15.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.16 | 980 | 17 |
View Market Depth
| Last trade - 15.08pm 30/09/2024 (20 minute delay) ? |
| NEU (ASX) Chart |